Risk Factors for Early Treatment Discontinuation Due to Toxicity Among Patients With Metastatic Castration-resistant Prostate Cancer Receiving Androgen Receptor-targeted Therapy

Chakrani, Z., Mellgard, G., Saffran, N., McCroskery, S., Taylor, N., Patel, M., Liaw, B., Galsky, M., Oh, W. K., Tsao, C.-K., & Patel, V. G. (2024). Risk Factors for Early Treatment Discontinuation Due to Toxicity Among Patients With Metastatic Castration-resistant Prostate Cancer Receiving Androgen Receptor–targeted Therapy. American Journal of Clinical Oncology, 47(6), 271–278. https://doi.org/10.1097/coc.0000000000001087
Authors:
Zakaria Chakrani
George Mellgard
Nathaniel Saffran
Stephen McCroskery
Nicole Taylor
Mann Patel
Bobby Liaw
Matthew Galsky
William K Oh
Che-Kai Tsao
Vaibhav G Patel
Affiliated Authors:
George Mellgard
Author Keywords:
androgen receptor therapy
metastatic castration-resistant prostate cancer
treatment discontinuation
Publication Type:
Article
Unique ID:
10.1097/coc.0000000000001087
PMID:
Publication Date:
Data Source:
PubMed

Record Created: